跳至主要内容
临床试验/NCT01591512
NCT01591512终止不适用

A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell

Fujirebio Diagnostics, Inc.4 个研究点 分布在 1 个国家目标入组 4 人开始时间: 2011年5月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
4
试验地点
4

研究概览

简要总结

The purpose of this study is to collect samples to evaluate the ProGRP and NSE assays independently as aids for monitoring the course of disease and therapy in subjects diagnosed with SCLC.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed diagnosis of SCLC or mixed SCLC/non-SCLC per histopathology results
  • Scheduled to undergo first-, second- or third-line treatment for SCLC, including chemotherapy, chemotherapy + radiation therapy, or combined concurrent chemoradiotherapy.
  • Able to understand and willing to provide Informed Consent

排除标准

  • No diagnosis of SCLC
  • Not scheduled to undergo treatment for the diagnosis of SCLC
  • Unable to provide Informed Consent

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验